Evidence map›Paper›PMID 16964288›Full record

ArticleOncogene2007

Characterizing a rat Brca2 knockout model.

M S Cotroneo, J D Haag, Y Zan, C C Lopez, P Thuwajit, G V Petukhova, R D Camerini-Otero, A Gendron-Fitzpatrick, A E Griep, C J Murphy and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Homologs of breast cancer genes in plants.Frontiers in plant science · 2011
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Mammary cancer susceptibility: human genes and rodent models.Mammalian genome : official journal of the International Mammalian Genome Society · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

M S CotroneoMcArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.
J D Haag
Y Zan
C C Lopez
P Thuwajit
G V Petukhova
R D Camerini-Otero
A Gendron-Fitzpatrick
A E Griep
C J Murphy
R R Dubielzig
M N Gould
University of Wisconsin–Madison · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

The different pathways involved in meiotic recombination in mammalsZIADK052033 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CAMERINI-OTERO, RAFAEL · 2009 to 2017
$7.0M
Induction and Selection for Loss of function MutationsR01CA106216 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI GOULD, MICHAEL N · 2003 to 2007
$1.6M
The different pathways involved in meiotic recombination in mammalsZ01DK052033 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CAMERINI-OTERO, RAFAEL · 2007 to 2008
$974k
GENE EXPRESSION AND HUMAN GENETICSZ01DK052008 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI CAMERINI-OTERO, RAFAEL · 1986 to 2006
–
NCI NIH HHS CA106216
6 · The paper itself

Abstract

Evidence exists that BRCA2 carriers may have an elevated risk of breast, ovarian, colon, prostate, and pancreatic cancer. In general, carriers are defined as individuals with protein truncating mutations within the BRCA2 gene. Many Brca2 knockout lines have been produced and characterized in the mouse. We previously produced a rat Brca2 knockout strain in which there is a nonsense mutation in exon 11 between BRC repeats 2 and 3, and a truncated protein is produced. Interestingly, while such a mutation in homozygous mice would lead to limited survival of approximately 3 months, the Brca2-/- rats are 100% viable and the vast majority live to over 1 year of age. Brca2-/- rats show a phenotype of growth inhibition and sterility in both sexes. Aspermatogenesis in the Brca2-/- rats is due to a failure of homologous chromosome synapsis. Long-term phenotypes include underdeveloped mammary glands, cataract formation and lifespan shortening due to the development of tumors and cancers in multiple organs. The establishment of the rat Brca2 knockout model provides a means to study the role of Brca2 in increasing cancer susceptibility and inducing a novel ocular phenotype not previously associated with this gene.

Indexed as

Genes, BRCA2AnimalsAnimals, Genetically ModifiedBase SequenceDisease Models, AnimalDNA PrimersFemaleMaleMammary Neoplasms, ExperimentalRatsRats, Sprague-DawleyDNA Primers

Identifiers

PMID16964288
OpenAlexW2168448345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.